SPY411.04-0.45 -0.11%
DIA337.04-0.82 -0.24%
IXIC13,833.50-66.68 -0.48%

Aprea Therapeutics Q4 EPS $(0.73) Down From $(0.64) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.73) per share. This is a 14.06 percent decrease over losses of $(0.64) per share from the same period last year.

· 03/16/2021 16:22
Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.73) per share. This is a 14.06 percent decrease over losses of $(0.64) per share from the same period last year.